Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular clucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA).

Kim Hørslev-Petersen; Merete Lund Hetland; P. Junker; Jan Pødenphanth; T. Ellingsen; P. Ahlquist; Hanne Merete Lindegaard; A. Linauskas; Annette Schlemmer; M.Y. Dam; I. Hansen; H.C. Horn; A. Jørgensen; Sophine Boysen Krintel; J. Raun; C.G. Ammitzbøll; Julia Sidenius Johansen; Mikkel Østergaard; K. Stengaard-Pedersen

Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular clucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA).

Kim Hørslev-Petersen, Merete Lund Hetland, P. Junker, Jan Pødenphanth, T. Ellingsen, P. Ahlquist, Hanne Merete Lindegaard, A. Linauskas, Annette Schlemmer, M.Y. Dam, I. Hansen, H.C. Horn, A. Jørgensen, Sophine Boysen Krintel, J. Raun, C.G. Ammitzbøll, Julia Sidenius Johansen, Mikkel Østergaard, K. Stengaard-Pedersen

Original language	English
Book series	Scandinavian Journal of Rheumatology. Supplement
Volume	41
Issue number	126 suppl.
Pages (from-to)	17-8
Number of pages	2
ISSN	0301-3847
Publication status	Published - 2012

Cite this

Hørslev-Petersen, K., Hetland, M. L., Junker, P., Pødenphanth, J., Ellingsen, T., Ahlquist, P., Lindegaard, H. M., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I., Horn, H. C., Jørgensen, A., Krintel, S. B., Raun, J., Ammitzbøll, C. G., Johansen, J. S., Østergaard, M., & Stengaard-Pedersen, K. (2012). Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular clucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA). Scandinavian Journal of Rheumatology. Supplement, 41(126 suppl.), 17-8.

Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular clucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA). / Hørslev-Petersen, Kim; Hetland, Merete Lund; Junker, P. et al.
In: Scandinavian Journal of Rheumatology. Supplement, Vol. 41, No. 126 suppl., 2012, p. 17-8.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Hørslev-Petersen, K, Hetland, ML, Junker, P, Pødenphanth, J, Ellingsen, T, Ahlquist, P, Lindegaard, HM, Linauskas, A, Schlemmer, A, Dam, MY, Hansen, I, Horn, HC, Jørgensen, A, Krintel, SB, Raun, J, Ammitzbøll, CG, Johansen, JS , Østergaard, M & Stengaard-Pedersen, K 2012, 'Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular clucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA).', Scandinavian Journal of Rheumatology. Supplement, vol. 41, no. 126 suppl., pp. 17-8.

Hørslev-Petersen K, Hetland ML, Junker P, Pødenphanth J, Ellingsen T, Ahlquist P et al. Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular clucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA). Scandinavian Journal of Rheumatology. Supplement. 2012;41(126 suppl.):17-8.

Hørslev-Petersen, Kim ; Hetland, Merete Lund ; Junker, P. et al. / Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular clucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA). In: Scandinavian Journal of Rheumatology. Supplement. 2012 ; Vol. 41, No. 126 suppl. pp. 17-8.

@article{da893e67ef634ac6a6702e312d5dace4,

title = "Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular clucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA).",

author = "Kim H{\o}rslev-Petersen and Hetland, \{Merete Lund\} and P. Junker and Jan P{\o}denphanth and T. Ellingsen and P. Ahlquist and Lindegaard, \{Hanne Merete\} and A. Linauskas and Annette Schlemmer and M.Y. Dam and I. Hansen and H.C. Horn and A. J{\o}rgensen and Krintel, \{Sophine Boysen\} and J. Raun and C.G. Ammitzb{\o}ll and Johansen, \{Julia Sidenius\} and Mikkel {\O}stergaard and K. Stengaard-Pedersen",

year = "2012",

language = "English",

volume = "41",

pages = "17--8",

journal = "Scandinavian Journal of Rheumatology. Supplement",

issn = "0301-3847",

publisher = "Taylor and Francis A.S.",

number = "126 suppl.",

}

TY - ABST

T1 - Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular clucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA).

AU - Hørslev-Petersen, Kim

AU - Hetland, Merete Lund

AU - Junker, P.

AU - Pødenphanth, Jan

AU - Ellingsen, T.

AU - Ahlquist, P.

AU - Lindegaard, Hanne Merete

AU - Linauskas, A.

AU - Schlemmer, Annette

AU - Dam, M.Y.

AU - Hansen, I.

AU - Horn, H.C.

AU - Jørgensen, A.

AU - Krintel, Sophine Boysen

AU - Raun, J.

AU - Ammitzbøll, C.G.

AU - Johansen, Julia Sidenius

AU - Østergaard, Mikkel

AU - Stengaard-Pedersen, K.

PY - 2012

Y1 - 2012

M3 - Conference abstract in journal

SN - 0301-3847

VL - 41

SP - 17

EP - 18

JO - Scandinavian Journal of Rheumatology. Supplement

JF - Scandinavian Journal of Rheumatology. Supplement

IS - 126 suppl.

ER -